Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids
Status:
Completed
Trial end date:
2006-10-26
Target enrollment:
Participant gender:
Summary
This study will compare two treatment strategies (doubling the dose of inhaled steroids or
adding a long acting beta2 agonist to the inhaled steroid at the same dose) in children not
controlled by inhaled steroid alone at medium dose. The fixed combination SERETIDE 100/50 one
inhalation twice daily will be compared to FLIXOTIDE 100 two inhalations twice daily.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance